Jeff Yass’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36,000
Closed -$108K 13777
2023
Q1
$108K Sell
36,000
-600
-2% -$1.79K ﹤0.01% 11237
2022
Q4
$109K Sell
36,600
-10,600
-22% -$31.7K ﹤0.01% 10879
2022
Q3
$141K Buy
47,200
+35,700
+310% +$87.7K ﹤0.01% 11325
2022
Q2
$34K Sell
11,500
-22,800
-66% -$70.7K ﹤0.01% 12171
2022
Q1
$132K Buy
+34,300
New +$142K ﹤0.01% 11688
2021
Q3
Sell
-11,600
Closed -$62K 14151
2021
Q2
$62K Buy
+11,600
New +$60.7K ﹤0.01% 12250
2019
Q3
Sell
-11,000
Closed -$64K 11303
2019
Q2
$64K Buy
+11,000
New +$72.5K ﹤0.01% 9782
2018
Q3
Sell
-22,100
Closed -$210K 10915
2018
Q2
$210K Buy
+22,100
New +$212K ﹤0.01% 8526

Other funds holding CO

Jeff Yass's CO Position: Q2 2023 in Review

Jeff Yass sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 13,333 shares — an estimated $39.8K sold.

Jeff Yass first reported a position in CO in Q2 2015 and held it in 20 quarters. The position peaked at $873K in Q2 2015. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Jeff Yass reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 13,333 Global Cord Blood Corporation shares in Q2 2023, an estimated $39.8K.
  • Jeff Yass first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 20 quarters.
  • Jeff Yass's Global Cord Blood Corporation position peaked at $873K in Q2 2015.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.